Dr. Borad on the SARAH and SIRveNIB Studies in Hepatocellular Carcinoma
May 12th 2018Mitesh J. Borad, MD, associate professor of medicine, consultant, Division of Hematology/Oncology, Mayo Clinic, discusses the results of the SARAH and SIRveNIB studies in patients with hepatocellular carcinoma.
Read More